Literature DB >> 14565953

Molecular cloning, genomic structure, and expression analysis of MUC20, a novel mucin protein, up-regulated in injured kidney.

Toshio Higuchi1, Takuya Orita, Setsuko Nakanishi, Ken Katsuya, Hirotaka Watanabe, Yoshiki Yamasaki, Iwao Waga, Toyomichi Nanayama, Yoshihisa Yamamoto, William Munger, Hong-Wei Sun, Ronald J Falk, J Charles Jennette, David A Alcorta, Huiping Li, Tadashi Yamamoto, Yutaka Saito, Motonao Nakamura.   

Abstract

Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis in the world. Here, we identify a cDNA encoding a novel mucin protein, shown previously to be up-regulated in IgAN patients, from a human kidney cDNA library. This protein contains a mucin tandem repeat of 19 amino acids consisting of many threonine, serine, and proline residues and likely to be extensively O-glycosylated; thus, this gene was classified in the mucin family and named MUC20. The human MUC20 gene contains at least four exons and is localized close to MUC4 on chromosome 3q29. We found variations in repeat numbers in the mucin tandem domain, suggesting polymorphism of this region. Northern blot and reverse transcription-PCR analyses revealed that human MUC20 mRNA was expressed most highly in kidney and moderately in placenta, colon, lung, prostate, and liver. Immunohistochemical analysis of human kidney revealed that MUC20 protein was localized in the proximal tubules. Immunoblotting analysis of MUC20 proteins produced in Madin-Darby canine kidney and HEK293 cells indicated the localization of MUC20 protein in a membrane fraction and extensive posttranslational modification. Immunoelectron microscopy of MUC20-producing Madin-Darby canine kidney cells demonstrated that MUC20 protein was localized on the plasma membrane. Expression of MUC20 mRNA in a human kidney cell line was up-regulated by tumor necrosis factor-alpha, phorbol 12-myristate 13-acetate, or lipopolysaccharide. Two species of MUC20 mRNA (hMUC20-L and hMUC20-S), resulting from alternative transcription, were identified in human tissue, whereas only one variant was observed in mouse tissues. Mouse MUC20 mRNA was expressed in the epithelial cells of proximal tubules, and the expression increased dramatically with the progression of lupus nephritis in the kidney of MRL/MpJ-lpr/lpr mice. Moreover, the expression of mouse MUC20 was augmented in renal tissues acutely injured by cisplatin or unilateral ureteral obstruction. These characteristics suggest that the production of MUC20 is correlated with development and progression of IgAN and other renal injuries.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14565953     DOI: 10.1074/jbc.M304558200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

Review 1.  Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells.

Authors:  S Bafna; S Kaur; S K Batra
Journal:  Oncogene       Date:  2010-03-29       Impact factor: 9.867

Review 2.  Mucins and toll-like receptors: kith and kin in infection and cancer.

Authors:  Shikha Tarang; Sushil Kumar; Surinder K Batra
Journal:  Cancer Lett       Date:  2012-02-03       Impact factor: 8.679

3.  The porcine MUC20 gene: molecular characterization and its association with susceptibility to enterotoxigenic Escherichia coli F4ab/ac.

Authors:  Huayuan Ji; Jun Ren; Xueming Yan; Xiang Huang; Bo Zhang; Zhiyan Zhang; Lusheng Huang
Journal:  Mol Biol Rep       Date:  2010-10-02       Impact factor: 2.316

4.  MUC16 in the lacrimal apparatus.

Authors:  Kristin Jäger; Guangxi Wu; Saadettin Sel; Fabian Garreis; Lars Bräuer; Friedrich P Paulsen
Journal:  Histochem Cell Biol       Date:  2007-01-09       Impact factor: 4.304

Review 5.  Mucin overproduction in chronic inflammatory lung disease.

Authors:  Hans-Peter Hauber; Susan C Foley; Qutayba Hamid
Journal:  Can Respir J       Date:  2006-09       Impact factor: 2.409

Review 6.  Immunogenetic programs for viral induction of mucous cell metaplasia.

Authors:  Michael J Holtzman; John T Battaile; Anand C Patel
Journal:  Am J Respir Cell Mol Biol       Date:  2006-03-16       Impact factor: 6.914

7.  Mammalian sialyltransferase ST3Gal-II: its exchange sialylation catalytic properties allow labeling of sialyl residues in mucin-type sialylated glycoproteins and specific gangliosides.

Authors:  E V Chandrasekaran; Jun Xue; Jie Xia; Robert D Locke; Shilpa A Patil; Sriram Neelamegham; Khushi L Matta
Journal:  Biochemistry       Date:  2011-10-13       Impact factor: 3.162

8.  Identification of oral squamous cell carcinoma markers MUC2 and SPRR1B downstream of TANGO.

Authors:  Tomonori Sasahira; Miyako Kurihara-Shimomura; Hiroyuki Shimomura; Anja Katrin Bosserhoff; Tadaaki Kirita
Journal:  J Cancer Res Clin Oncol       Date:  2021-02-23       Impact factor: 4.553

Review 9.  Current status of mucins in the diagnosis and therapy of cancer.

Authors:  Satyanarayana Rachagani; Maria P Torres; Nicolas Moniaux; Surinder K Batra
Journal:  Biofactors       Date:  2009 Nov-Dec       Impact factor: 6.113

10.  Mucins in ovarian cancer diagnosis and therapy.

Authors:  Subhash C Chauhan; Deepak Kumar; Meena Jaggi
Journal:  J Ovarian Res       Date:  2009-12-24       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.